Rosacea is a common inflammatory dermatologic condition that affects the midface and eyes. Although the etiology of rosacea is not fully understood, an augmented response of the innate immune system and neurovascular pathways to certain triggers are considered to be major factors in the chronic inflammatory process associated with this condition. Clinical features include flushing, telangiectasias, erythema, papules and pustules, and rhinophyma. More than 50% of patients with rosacea have ocular manifestations. Ocular rosacea is inflammation that causes redness, burning and itching of the eyes. The symptoms of rosacea can be treated effectively, however, rosacea is a chronic condition with exacerbations and remissions, which requires long-term therapy to maintain symptomatic control.
In a survey conducted by international institute of Ocular rosacea, it was found that more serious problems got arise in about 5% of those with Ocular Rosacea: is because of Iritis, inflammation of the iris causing pain & Keratitis, ulceration of the cornea. Topical 0.5% brimonidine gel to camouflage redness of immature scars. Prognosis of 234 rosacea patients according to clinical subtype: The significance of central facial erythema in the prognosis of rosacea. Extreme Eyelid Lymphedema Associated with Rosacea (Morbihan Disease): Case Series, Literature Review, and Therapeutic Considerations.